Loading your page…
Leukemia, Myeloid
Marketing Authorisation Holder: Janssen-Cilag International N.V.
EMA Authorisation: 20/09/2012
INN: decitabine
AI Drug & Interaction Analysis
Free account required
Ask Osler about Dacogen: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.
